News
GLMD
1.365
-6.51%
-0.095
Weekly Report: what happened at GLMD last week (0324-0328)?
Weekly Report · 4d ago
Weekly Report: what happened at GLMD last week (0317-0321)?
Weekly Report · 03/24 10:27
Galmed Pharmaceuticals Secures New Patent for NASH Therapy
TipRanks · 03/20 21:52
Galmed Pharmaceuticals Announces The Grant Of A New Patent Related To Aramchol; Patent Covers The Use Of A Combination Therapy Of Aramchol And Resmetirom For The Treatment Of Non-Alcoholic Steatohepatitis, Also Known As Metabolic Dysfunction-Associated Steatohepatitis, And Liver Fibrosis
Benzinga · 03/20 12:57
Weekly Report: what happened at GLMD last week (0310-0314)?
Weekly Report · 03/17 10:34
Weekly Report: what happened at GLMD last week (0303-0307)?
Weekly Report · 03/10 10:35
Galmed Research And Development Granted U.S. Patent #12239712 Combination therapy for the treatment of liver disease
Benzinga · 03/04 19:34
Weekly Report: what happened at GLMD last week (0224-0228)?
Weekly Report · 03/03 10:35
Weekly Report: what happened at GLMD last week (0217-0221)?
Weekly Report · 02/24 10:34
Weekly Report: what happened at GLMD last week (0210-0214)?
Weekly Report · 02/17 10:33
Weekly Report: what happened at GLMD last week (0203-0207)?
Weekly Report · 02/10 10:29
Weekly Report: what happened at GLMD last week (0127-0131)?
Weekly Report · 02/03 10:32
Weekly Report: what happened at GLMD last week (0120-0124)?
Weekly Report · 01/27 10:34
Weekly Report: what happened at GLMD last week (0113-0117)?
Weekly Report · 01/20 10:28
Weekly Report: what happened at GLMD last week (0106-0110)?
Weekly Report · 01/13 10:29
Weekly Report: what happened at GLMD last week (1230-0103)?
Weekly Report · 01/06 10:34
Weekly Report: what happened at GLMD last week (1223-1227)?
Weekly Report · 12/30/2024 10:30
Weekly Report: what happened at GLMD last week (1216-1220)?
Weekly Report · 12/23/2024 10:35
Weekly Report: what happened at GLMD last week (1209-1213)?
Weekly Report · 12/16/2024 10:35
Weekly Report: what happened at GLMD last week (1202-1206)?
Weekly Report · 12/09/2024 10:34
More
Webull provides a variety of real-time GLMD stock news. You can receive the latest news about Galmed Pharmaceu through multiple platforms. This information may help you make smarter investment decisions.
About GLMD
More
Galmed Pharmaceuticals Ltd. is an Israel-based biopharmaceutical company dedicated to the development of therapeutics for the treatment of liver diseases. The Company is focused its research and development efforts on addressing unmet medical needs in the field of liver health. The Company's flagship product is Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule. Aramchol is aimed to be effective in the treatment of non-alcoholic steatohepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus. The Company's drug aims to be efficient treatment of NASH, a chronic liver disease characterized by fat accumulation, inflammation, and fibrosis, which can lead to cirrhosis and liver cancer if left untreated.